Author Topic: (Abst.) Tecfidera better at preventing relapses than Aubagio  (Read 134 times)

0 Members and 0 Guests are viewing this topic.

Offline agate

  • Administrator
  • *****
  • Posts: 9419
  • MS diagnosed 1980
  • Location: Pacific Northwest
(Abst.) Tecfidera better at preventing relapses than Aubagio
« on: March 18, 2019, 08:25:17 am »
This study, published in Neurology, showed Tecfidera to be better than Aubagio at preventing relapses and less likely to be discontinued due to disease breakthrough: From PubMed, March 17, 2019--"Comparative effectiveness of teriflunomide and dimethyl fumarate: A nationwide cohort study":


https://www.ncbi.nlm.nih.gov/pubmed/30877188
MS Speaks--online for 16 years

SPMS, diagnosed 1980. Avonex 2001-2004. Copaxone 2007-2010. Glatopa (glatiramer acetate 40mg 3 times/week) since 12/16/20.

 

Related Topics

  Subject / Started by Replies Last post
0 Replies
171 Views
Last post May 16, 2017, 12:06:36 pm
by agate
0 Replies
188 Views
Last post September 23, 2017, 04:24:24 pm
by agate
0 Replies
80 Views
Last post May 12, 2019, 11:44:22 am
by agate
0 Replies
42 Views
Last post November 30, 2019, 03:22:14 pm
by agate
0 Replies
34 Views
Last post June 21, 2021, 09:08:28 pm
by agate